Nektar Therapeutics (NKTR)
1.76
+0.16
(+10.00%)
USD |
NASDAQ |
May 10, 16:00
1.79
+0.03
(+1.70%)
After-Hours: 20:00
Nektar Therapeutics Cash and Short Term Investments (Quarterly): 303.62M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 303.62M |
| September 30, 2023 | 372.66M |
| June 30, 2023 | 409.43M |
| March 31, 2023 | 456.83M |
| December 31, 2022 | 504.98M |
| September 30, 2022 | 546.39M |
| June 30, 2022 | 619.32M |
| March 31, 2022 | 667.02M |
| December 31, 2021 | 733.96M |
| September 30, 2021 | 921.08M |
| June 30, 2021 | 1.000B |
| March 31, 2021 | 1.037B |
| December 31, 2020 | 1.062B |
| September 30, 2020 | 956.01M |
| June 30, 2020 | 1.038B |
| March 31, 2020 | 1.346B |
| December 31, 2019 | 1.325B |
| September 30, 2019 | 1.496B |
| June 30, 2019 | 1.515B |
| March 31, 2019 | 1.389B |
| December 31, 2018 | 1.335B |
| September 30, 2018 | 1.420B |
| June 30, 2018 | 1.824B |
| March 31, 2018 | 296.66M |
| December 31, 2017 | 296.13M |
| Date | Value |
|---|---|
| September 30, 2017 | 352.57M |
| June 30, 2017 | 265.55M |
| March 31, 2017 | 358.52M |
| December 31, 2016 | 389.10M |
| September 30, 2016 | 253.51M |
| June 30, 2016 | 274.85M |
| March 31, 2016 | 288.32M |
| December 31, 2015 | 308.94M |
| September 30, 2015 | 267.82M |
| June 30, 2015 | 254.66M |
| March 31, 2015 | 300.80M |
| December 31, 2014 | 237.82M |
| September 30, 2014 | 236.64M |
| June 30, 2014 | 276.44M |
| March 31, 2014 | 284.07M |
| December 31, 2013 | 237.03M |
| September 30, 2013 | 183.55M |
| June 30, 2013 | 201.88M |
| March 31, 2013 | 236.20M |
| December 31, 2012 | 277.19M |
| September 30, 2012 | 319.28M |
| June 30, 2012 | 432.87M |
| March 31, 2012 | 382.11M |
| December 31, 2011 | 241.17M |
| September 30, 2011 | 266.49M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
303.62M
Minimum
Dec 2023
1.515B
Maximum
Jun 2019
858.46M
Average
921.08M
Median
Sep 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Stereotaxis Inc | 19.82M |
| Vanda Pharmaceuticals Inc | 388.26M |
| Cara Therapeutics Inc | 100.76M |
| Avid Bioservices Inc | 30.71M |
| Rigel Pharmaceuticals Inc | 56.93M |